AVAH

Aveanna Healthcare Hldgs

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Healthcare

industry

Medical Care Facilities

Exchange

Nasdaq

County of HQ

United States

Next Earnings Date

05/14/26

Business Summary

Aveanna Healthcare Holdings operates as a provider of home-based and specialized medical care services, generating revenue through recurring patient care reimbursements across its network. Cash flow is driven by volume of visits and acuity of care, making scale and payer relationships central to profitability. Its moat is operational density: coordinating clinicians, compliance, and reimbursement systems across fragmented local markets. The business wins by aggregating demand, managing regulatory complexity, and leveraging centralized administration to extract margin from decentralized care delivery.

VALUATION

P/E

5.9

Market Cap ($M USD)

$1,352

Forward P/E

8.9

PEG

-

PRICE TO SALES

0.6

PRICE TO BOOK

6.9

EV / EBITDA

9.9

5-Year Average P/E

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

-

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

$1.11

Next Year EPS Growth Estimate

$0.70

Next Year Revenue Growth Estimate

5.60%

Return on Equity (ROE)

115.30%

Operating Margin

10.70%

Debt-to-Equity

7.8

Piotroski F-Score

6

Altman Z-Score

1.4

Return on Invested Capital (ROIC)

19.70%%

Current Ratio

1.3

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At 5.9x earnings and 0.6x sales, AVAH screens statistically cheap, but this is not a clean deep-value setup. The Forward P/E of 8.9 implies earnings normalization or compression versus the current 9.9 EPS figure, suggesting the market does not fully trust the durability of current profitability. More concerning is the Altman Z-Score of 1.4, which signals elevated financial distress risk and materially weak balance sheet safety. This is a leveraged equity trading at a low multiple for a reason: the market is discounting solvency risk and volatile forward fundamentals rather than overlooking a pristine compounder.

AI Exposure / Tech Reliance

As a Medical Care Facilities operator in Healthcare, AVAH operates in a service-heavy, labor-intensive segment where AI primarily enhances scheduling, patient monitoring, and administrative efficiency rather than replacing core services. The opportunity lies in cost optimization and margin stability, not exponential AI-driven revenue expansion. Tech resilience will depend on operational execution, not proprietary platforms.

The Bull Case

A value or GARP investor could argue that 19.70% ROIC against a 5.60% ROE indicates strong capital productivity at the operating level despite equity distortion from leverage. The Piotroski F-Score of 6 signals middling but positive fundamental momentum, not deterioration. A 115.30% operating margin, if sustainable, implies significant pricing power or accounting leverage that dramatically amplifies earnings versus revenue, helping justify the 7.8 TTM yield. Trading at 0.6x sales with a modest 1.3 current ratio and a sub-10 Forward P/E, the stock offers asymmetric upside if balance sheet pressure stabilizes and projected EPS of $1.11 next year proves conservative.

The Bear Case

The red flags are impossible to ignore. Debt/Equity of 10.70% combined with an Altman Z-Score of 1.4 places the company in a financially fragile zone, where any reimbursement shock or cost spike could impair equity holders. The absence of a PEG ratio and missing short interest transparency reduce visibility into forward growth quality, while institutional ownership at $10.00 suggests limited sophisticated sponsorship. The projected sales growth figure of $0.70 lacks context and, paired with a higher Forward P/E than trailing P/E, implies decelerating earnings power rather than acceleration.

Market Sentiment & Smart Money

Short Interest %

5.80%

Analyst Consensus

2

Average Analyst Price Target

$10.00

Institutional Ownership %

90.20%

1-Year Beta

1.3

Insider Buying % (6 Mo)

5.70%%

Distance to 52-Week High

60.30%%

Distance to 52-Week Low

166.80%%